Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid disease and increased cardiovascular risk.

Moffat J Nyirenda1, David N Clark, Alan R Finlayson

  • 1Endocrine Clinic, Royal Infirmary of Edinburgh, Edinburgh, Scotland.

Thyroid : Official Journal of the American Thyroid Association
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four Year Clinical and Cost Effectiveness of Vaginal Pessary Self-Management Versus Clinic-Based Care for Pelvic Organ Prolapse (TOPSY): Long Term Follow-Up of a Randomised Controlled Superiority Trial.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Pain management and patient education interventions to increase physical activity in people with intermittent claudication (PrEPAID): a feasibility randomised controlled trial in the UK.

BMJ open·2025
Same author

Clinical and cost-effectiveness of pessary self-management versus clinic-based care for pelvic organ prolapse in women: the TOPSY RCT with process evaluation.

Health technology assessment (Winchester, England)·2024
Same author

Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024
Same author

Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.

Health technology assessment (Winchester, England)·2024
Same author

Clinical effectiveness of vaginal pessary self-management vs clinic-based care for pelvic organ prolapse (TOPSY): a randomised controlled superiority trial.

EClinicalMedicine·2023

Even after thyroid function is normalized, treated thyroid diseases like Graves' disease and toxic multinodular goiter are linked to higher cardiovascular risks. Hashimoto's thyroiditis also increases vascular risk in older adults.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Thyroid dysfunction effects are typically reversible upon euthyroidism.
  • However, data suggest subclinical or treated thyroid disease correlates with elevated vascular risk.
  • The specific nature and treatment of thyroid disease's impact on vascular risk require further investigation.

Purpose of the Study:

  • To determine the extent of vascular risk associated with treated thyroid disease.
  • To explore if the type and treatment of thyroid disease influence this vascular risk.
  • To compare cardiovascular and cerebrovascular disease hospitalizations and mortality in thyroid disease patients versus controls.

Main Methods:

  • Utilized medical record linkage to match patients with treated thyroid disease to national hospital discharge and death records.

Related Experiment Videos

  • Assessed hospitalizations for cardiovascular or cerebrovascular disease and death.
  • Compared outcomes between patients with various thyroid disease etiologies and control groups.
  • Main Results:

    • Graves' disease patients showed a 1.42-fold increased risk of cardiovascular hospitalizations (p < 0.001).
    • Toxic multinodular goiter was associated with a 1.50-fold increased risk of cardiovascular disease (p = 0.008).
    • Hashimoto's thyroiditis patients over 50 had a threefold increase in cardiovascular admissions compared to controls (23.5% vs. 6.5%, p = 0.003).

    Conclusions:

    • Different forms of treated thyroid disease are linked to increased long-term vascular risk, even after achieving euthyroidism.
    • The underlying mechanisms for this persistent vascular risk are not fully understood.
    • These mechanisms may not be solely dependent on thyroid hormone levels.